跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Maxi Grape Seed 60000mg Capsule One-A-Day - TGA Drug Approval Details
Approvals
/
TGA
/
Maxi Grape Seed 60000mg Capsule One-A-Day
Approved
STANDARD
Maxi Grape Seed 60000mg Capsule One-A-Day
B Pure Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
7249ef0b404fab7a
Company
B Pure Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
7249ef0b404fab7a
Product Name
Maxi Grape Seed 60000mg Capsule One-A-Day
Artg Id
409313
Artg Name
Maxi Grape Seed 60000mg Capsule One-A-Day
Sponsor
B Pure Australia Pty Ltd
Artg Date
2023-05-22
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
LI
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
7249ef0b404fab7a
Type
Standard
Back to TGA Approvals